FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

17220911000001102: Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Jun 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
59898501000001111 Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
59898601000001110 Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Is a Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has active ingredient Hydrochlorothiazide false Inferred relationship Existential restriction modifier
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has active ingredient Olmesartan medoxomil false Inferred relationship Existential restriction modifier
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has specific active ingredient Olmesartan medoxomil true Inferred relationship Existential restriction modifier
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Is a Olmetec Plus true Inferred relationship Existential restriction modifier
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) 28 tablet Has AMP True Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start